| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 2.65e-12 | 4 | 27 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 2.65e-12 | 4 | 27 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.32e-11 | 5 | 27 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 9.25e-11 | 7 | 27 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 3.32e-10 | 9 | 27 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 5.53e-10 | 10 | 27 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 1.88e-09 | 13 | 27 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 4.74e-07 | 372 | 27 | 7 | GO:0061630 | |
| GeneOntologyMolecularFunction | acyltransferase activity | TRIM49D1 TRIM49 BFAR TRIM51 ZDHHC17 RNF103 TRIM49B DGAT1 TRIM49C | 4.77e-07 | 775 | 27 | 9 | GO:0016746 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 7.46e-07 | 398 | 27 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 8.62e-07 | 55 | 27 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 2.36e-06 | 473 | 27 | 7 | GO:0004842 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 2.86e-06 | 74 | 27 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 3.98e-06 | 512 | 27 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 5.12e-06 | 532 | 27 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 8.79e-04 | 323 | 27 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.60e-03 | 75 | 27 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | zinc ion binding | 6.23e-03 | 891 | 27 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.03e-03 | 100 | 27 | 2 | GO:0030594 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 1.16e-11 | 5 | 27 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 5.48e-09 | 17 | 27 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 5.48e-09 | 17 | 27 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 5.48e-09 | 17 | 27 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 7.03e-09 | 18 | 27 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.03e-08 | 23 | 27 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 4.00e-08 | 27 | 27 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 2.40e-07 | 106 | 27 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.00e-07 | 47 | 27 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.67e-07 | 13 | 27 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 6.04e-07 | 52 | 27 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 9.94e-07 | 141 | 27 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 1.03e-06 | 142 | 27 | 5 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 1.03e-06 | 142 | 27 | 5 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 1.03e-06 | 142 | 27 | 5 | GO:0034032 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.38e-06 | 73 | 27 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 2.52e-06 | 74 | 27 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 2.52e-06 | 74 | 27 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRIM49D1 TRIM49 BFAR TRIM51 RNF103 TRIM49B ZRANB1 WBP1L TRIM49C | 3.26e-06 | 1009 | 27 | 9 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRIM49D1 TRIM49 BFAR TRIM51 RNF103 TRIM49B ZRANB1 WBP1L TRIM49C | 5.44e-06 | 1074 | 27 | 9 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein ubiquitination | 6.30e-06 | 811 | 27 | 8 | GO:0016567 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 9.19e-06 | 222 | 27 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 1.12e-05 | 619 | 27 | 7 | GO:0006163 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | 1.27e-05 | 893 | 27 | 8 | GO:0032446 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 1.56e-05 | 652 | 27 | 7 | GO:0072521 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 1.78e-05 | 121 | 27 | 4 | GO:0006576 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 2.13e-05 | 684 | 27 | 7 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 2.27e-05 | 691 | 27 | 7 | GO:0006753 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 3.11e-05 | 286 | 27 | 5 | GO:0042445 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 3.34e-05 | 142 | 27 | 4 | GO:0018958 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 3.93e-05 | 148 | 27 | 4 | GO:0009308 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 4.31e-05 | 512 | 27 | 6 | GO:0009150 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 4.43e-05 | 767 | 27 | 7 | GO:0055086 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 5.33e-05 | 160 | 27 | 4 | GO:0051384 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 5.40e-05 | 533 | 27 | 6 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 5.80e-05 | 540 | 27 | 6 | GO:0019693 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 7.38e-05 | 10 | 27 | 2 | GO:0042420 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 7.90e-05 | 64 | 27 | 3 | GO:1903351 | |
| GeneOntologyBiologicalProcess | response to dopamine | 8.66e-05 | 66 | 27 | 3 | GO:1903350 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 9.01e-05 | 11 | 27 | 2 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 9.01e-05 | 11 | 27 | 2 | GO:0019614 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 9.36e-05 | 185 | 27 | 4 | GO:0031960 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 9.47e-05 | 68 | 27 | 3 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 9.47e-05 | 68 | 27 | 3 | GO:0071870 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 9.89e-05 | 365 | 27 | 5 | GO:0006790 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 1.17e-04 | 73 | 27 | 3 | GO:0071869 | |
| GeneOntologyBiologicalProcess | response to monoamine | 1.22e-04 | 74 | 27 | 3 | GO:0071867 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | 1.22e-04 | 1226 | 27 | 8 | GO:1901135 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 1.49e-04 | 14 | 27 | 2 | GO:0019336 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.74e-04 | 412 | 27 | 5 | GO:0006066 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 3.09e-04 | 20 | 27 | 2 | GO:0042402 | |
| GeneOntologyBiologicalProcess | amine catabolic process | 3.75e-04 | 22 | 27 | 2 | GO:0009310 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | 5.23e-04 | 1142 | 27 | 7 | GO:0019637 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 5.32e-04 | 525 | 27 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 1.31e-03 | 641 | 27 | 5 | GO:1901615 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.37e-03 | 376 | 27 | 4 | GO:0008202 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.44e-03 | 381 | 27 | 4 | GO:0048545 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.74e-03 | 684 | 27 | 5 | GO:0010817 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 2.00e-03 | 1048 | 27 | 6 | GO:0014070 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 2.07e-03 | 421 | 27 | 4 | GO:0044282 | |
| GeneOntologyBiologicalProcess | dopamine metabolic process | 2.18e-03 | 53 | 27 | 2 | GO:0042417 | |
| GeneOntologyBiologicalProcess | eating behavior | 2.43e-03 | 56 | 27 | 2 | GO:0042755 | |
| GeneOntologyBiologicalProcess | icosanoid secretion | 2.43e-03 | 56 | 27 | 2 | GO:0032309 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 4.10e-03 | 73 | 27 | 2 | GO:0071715 | |
| MousePheno | enlarged gallbladder | 4.89e-08 | 28 | 19 | 4 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 8.56e-08 | 32 | 19 | 4 | MP:0020134 | |
| MousePheno | abnormal gallbladder morphology | 1.13e-06 | 60 | 19 | 4 | MP:0005084 | |
| MousePheno | abnormal mammary gland morphology | 5.77e-06 | 201 | 19 | 5 | MP:0000627 | |
| MousePheno | abnormal apocrine gland morphology | 5.77e-06 | 201 | 19 | 5 | MP:0013554 | |
| MousePheno | abnormal biliary tract morphology | 1.64e-05 | 117 | 19 | 4 | MP:0005083 | |
| MousePheno | abnormal skeletal muscle morphology | 4.05e-05 | 508 | 19 | 6 | MP:0000759 | |
| MousePheno | abnormal liver physiology | 1.58e-04 | 401 | 19 | 5 | MP:0000609 | |
| MousePheno | abnormal hepatobiliary system physiology | 2.26e-04 | 433 | 19 | 5 | MP:0002139 | |
| MousePheno | abnormal skin morphology | 3.56e-04 | 1455 | 19 | 8 | MP:0002060 | |
| MousePheno | abnormal blood-brain barrier function | 4.35e-04 | 23 | 19 | 2 | MP:0005167 | |
| MousePheno | enlarged lymph nodes | 4.69e-04 | 507 | 19 | 5 | MP:0000702 | |
| MousePheno | enlarged thymus | 5.64e-04 | 292 | 19 | 4 | MP:0000709 | |
| MousePheno | abnormal exocrine gland morphology | 6.92e-04 | 853 | 19 | 6 | MP:0013558 | |
| MousePheno | abnormal lymph node size | 7.44e-04 | 561 | 19 | 5 | MP:0000701 | |
| MousePheno | enlarged heart | 1.01e-03 | 916 | 19 | 6 | MP:0000274 | |
| Domain | BBOX | 3.68e-08 | 69 | 26 | 5 | SM00336 | |
| Domain | Butyrophylin | 3.96e-08 | 70 | 26 | 5 | IPR003879 | |
| Domain | - | 4.25e-08 | 71 | 26 | 5 | 4.10.45.10 | |
| Domain | zf-B_box | 4.57e-08 | 72 | 26 | 5 | PF00643 | |
| Domain | ZF_BBOX | 7.79e-08 | 80 | 26 | 5 | PS50119 | |
| Domain | Znf_B-box | 8.29e-08 | 81 | 26 | 5 | IPR000315 | |
| Domain | - | 1.12e-07 | 449 | 26 | 8 | 3.30.40.10 | |
| Domain | ZF_RING_2 | 1.24e-07 | 298 | 26 | 7 | PS50089 | |
| Domain | Znf_RING/FYVE/PHD | 1.33e-07 | 459 | 26 | 8 | IPR013083 | |
| Domain | RING | 1.46e-07 | 305 | 26 | 7 | SM00184 | |
| Domain | Sulfotransferase_dom | 1.69e-07 | 36 | 26 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.69e-07 | 36 | 26 | 4 | PF00685 | |
| Domain | SPRY | 1.75e-07 | 94 | 26 | 5 | PF00622 | |
| Domain | SPRY_dom | 1.75e-07 | 94 | 26 | 5 | IPR003877 | |
| Domain | B30.2/SPRY | 1.85e-07 | 95 | 26 | 5 | IPR001870 | |
| Domain | B302_SPRY | 1.85e-07 | 95 | 26 | 5 | PS50188 | |
| Domain | Znf_RING | 2.29e-07 | 326 | 26 | 7 | IPR001841 | |
| Domain | ZF_RING_1 | 2.41e-06 | 291 | 26 | 6 | PS00518 | |
| Domain | SPRY | 6.07e-06 | 87 | 26 | 4 | SM00449 | |
| Domain | WBP1-like | 1.12e-05 | 4 | 26 | 2 | IPR021684 | |
| Domain | WBP-1 | 1.12e-05 | 4 | 26 | 2 | PF11669 | |
| Domain | ConA-like_dom | 1.14e-05 | 219 | 26 | 5 | IPR013320 | |
| Domain | Znf_C3HC4_RING-type | 1.71e-03 | 172 | 26 | 3 | IPR018957 | |
| Domain | zf-C3HC4 | 3.57e-03 | 223 | 26 | 3 | PF00097 | |
| Domain | - | 1.87e-02 | 746 | 26 | 4 | 3.40.50.300 | |
| Domain | Znf_RING_CS | 2.14e-02 | 163 | 26 | 2 | IPR017907 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 5.53e-12 | 5 | 16 | 4 | M47807 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.31e-10 | 39 | 16 | 5 | MM15695 | |
| Pathway | KEGG_SULFUR_METABOLISM | 7.86e-10 | 13 | 16 | 4 | M18256 | |
| Pathway | WP_ESTROGEN_METABOLISM | 8.00e-09 | 22 | 16 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 9.67e-09 | 23 | 16 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 1.16e-08 | 24 | 16 | 4 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.58e-08 | 29 | 16 | 4 | M45015 | |
| Pathway | WP_RETINOL_METABOLISM | 1.46e-07 | 44 | 16 | 4 | MM15851 | |
| Pathway | REACTOME_DRUG_ADME | 1.60e-07 | 119 | 16 | 5 | MM15692 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 8.08e-07 | 17 | 16 | 3 | M39483 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.32e-06 | 107 | 16 | 4 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 5.73e-06 | 109 | 16 | 4 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.73e-06 | 109 | 16 | 4 | M18788 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.81e-05 | 6 | 16 | 2 | M39437 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 2.19e-05 | 153 | 16 | 4 | MM15844 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.91e-05 | 219 | 16 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 9.07e-05 | 220 | 16 | 4 | M10320 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 1.06e-03 | 43 | 16 | 2 | M39554 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.06e-03 | 183 | 16 | 3 | M39588 | |
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 25370010 | ||
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 33414449 | ||
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 8943792 | ||
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 2.88e-13 | 4 | 27 | 4 | 12390022 | |
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 24318996 | ||
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 8424956 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 24802129 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 11389699 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 29908303 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 25053625 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 2.20e-12 | 19 | 27 | 5 | 22144910 | |
| Pubmed | 1.01e-11 | 7 | 27 | 4 | 9370299 | ||
| Pubmed | 1.01e-11 | 7 | 27 | 4 | 12438748 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 2.01e-11 | 8 | 27 | 4 | 10594240 | |
| Pubmed | 3.62e-11 | 9 | 27 | 4 | 9166597 | ||
| Pubmed | 3.62e-11 | 9 | 27 | 4 | 8887328 | ||
| Pubmed | 3.62e-11 | 9 | 27 | 4 | 9177785 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 3.62e-11 | 9 | 27 | 4 | 23207770 | |
| Pubmed | 3.62e-11 | 9 | 27 | 4 | 8468045 | ||
| Pubmed | 3.62e-11 | 9 | 27 | 4 | 19548878 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 3.62e-11 | 9 | 27 | 4 | 9060415 | |
| Pubmed | 6.03e-11 | 10 | 27 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 9.47e-11 | 11 | 27 | 4 | 7613026 | |
| Pubmed | 9.47e-11 | 11 | 27 | 4 | 10720750 | ||
| Pubmed | 9.47e-11 | 11 | 27 | 4 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 9.47e-11 | 11 | 27 | 4 | 9034160 | |
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 9.47e-11 | 11 | 27 | 4 | 8954725 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 1.42e-10 | 12 | 27 | 4 | 7706460 | |
| Pubmed | 2.05e-10 | 13 | 27 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 2.05e-10 | 13 | 27 | 4 | 17425406 | |
| Pubmed | 3.91e-10 | 15 | 27 | 4 | 19703589 | ||
| Pubmed | 3.91e-10 | 15 | 27 | 4 | 1741163 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 4.17e-10 | 3 | 27 | 3 | 8363592 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 8912648 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 9855620 | ||
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 20056724 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 32152050 | ||
| Pubmed | 1.71e-09 | 21 | 27 | 4 | 32301970 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 4.99e-08 | 10 | 27 | 3 | 11535246 | |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 9.56e-08 | 55 | 27 | 4 | 19468303 | |
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 2.86e-07 | 72 | 27 | 4 | 8075499 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20417180 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8093002 | ||
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 5.80e-07 | 2 | 27 | 2 | 38069221 | |
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 5.80e-07 | 2 | 27 | 2 | 14871892 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 11207031 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 5.80e-07 | 2 | 27 | 2 | 20936502 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12469224 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31145702 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 5.80e-07 | 2 | 27 | 2 | 10762004 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10617600 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16133548 | ||
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 5.80e-07 | 2 | 27 | 2 | 8117269 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10543947 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8033246 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 9566757 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 5.80e-07 | 2 | 27 | 2 | 23358261 | |
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 5.80e-07 | 2 | 27 | 2 | 7581483 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29705271 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26291395 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15752422 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 26611713 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 26455829 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 7695643 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 18259693 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 1.74e-06 | 3 | 27 | 2 | 26067475 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 7961757 | ||
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 1.74e-06 | 3 | 27 | 2 | 24039991 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 8661000 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 26169578 | ||
| Pubmed | Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. | 8.69e-06 | 6 | 27 | 2 | 15358107 | |
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 24136195 | ||
| Pubmed | Human chromosome 11 DNA sequence and analysis including novel gene identification. | 3.29e-05 | 80 | 27 | 3 | 16554811 | |
| Pubmed | Common variants at five new loci associated with early-onset inflammatory bowel disease. | 3.81e-05 | 12 | 27 | 2 | 19915574 | |
| Pubmed | Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. | 6.06e-05 | 15 | 27 | 2 | 18632753 | |
| Pubmed | 6.92e-05 | 16 | 27 | 2 | 12419832 | ||
| Pubmed | 1.94e-04 | 376 | 27 | 4 | 24154525 | ||
| Pubmed | 2.49e-04 | 30 | 27 | 2 | 20529763 | ||
| Pubmed | 4.01e-04 | 38 | 27 | 2 | 20214802 | ||
| Pubmed | 4.46e-04 | 193 | 27 | 3 | 19343046 | ||
| Interaction | SULT1A3 interactions | 6.43e-11 | 24 | 24 | 5 | int:SULT1A3 | |
| Interaction | SULT1A4 interactions | 1.54e-09 | 14 | 24 | 4 | int:SULT1A4 | |
| Interaction | SULT1C2 interactions | 5.92e-09 | 19 | 24 | 4 | int:SULT1C2 | |
| Interaction | SULT1A1 interactions | 1.41e-08 | 67 | 24 | 5 | int:SULT1A1 | |
| Interaction | SULT2A1 interactions | 2.43e-07 | 11 | 24 | 3 | int:SULT2A1 | |
| Interaction | SULT1A2 interactions | 1.42e-06 | 19 | 24 | 3 | int:SULT1A2 | |
| Interaction | SULT4A1 interactions | 2.95e-06 | 24 | 24 | 3 | int:SULT4A1 | |
| Interaction | SULT1B1 interactions | 3.79e-05 | 8 | 24 | 2 | int:SULT1B1 | |
| Interaction | SUMF2 interactions | 4.62e-05 | 59 | 24 | 3 | int:SUMF2 | |
| Interaction | SULT2B1 interactions | 5.10e-05 | 61 | 24 | 3 | int:SULT2B1 | |
| Interaction | SULT1C3 interactions | 7.43e-05 | 11 | 24 | 2 | int:SULT1C3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 2.07e-05 | 278 | 27 | 4 | chr16p11 | |
| Cytoband | 16p12.1 | 9.91e-05 | 25 | 27 | 2 | 16p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q14 | 1.06e-04 | 156 | 27 | 3 | chr11q14 | |
| Cytoband | 11q14.3 | 1.63e-04 | 32 | 27 | 2 | 11q14.3 | |
| Cytoband | 11p15.5 | 2.20e-03 | 118 | 27 | 2 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p13 | 3.08e-03 | 140 | 27 | 2 | chr2p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.84e-02 | 355 | 27 | 2 | chr8q24 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.08e-09 | 14 | 20 | 4 | 762 | |
| GeneFamily | Ring finger proteins | 1.14e-08 | 275 | 20 | 7 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 5.25e-08 | 95 | 20 | 5 | 59 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 7.97e-09 | 24 | 26 | 4 | MM1317 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.05e-08 | 75 | 26 | 5 | MM1084 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 4.30e-07 | 157 | 26 | 5 | MM1099 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 5.93e-07 | 68 | 26 | 4 | MM770 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 1.39e-06 | 84 | 26 | 4 | MM873 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 3.80e-06 | 108 | 26 | 4 | MM1334 | |
| Coexpression | LE_EGR2_TARGETS_DN | 5.22e-06 | 117 | 26 | 4 | MM1139 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 9.21e-06 | 135 | 26 | 4 | MM753 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 9.44e-06 | 5 | 26 | 2 | M41007 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 1.29e-05 | 147 | 26 | 4 | MM3753 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.63e-05 | 156 | 26 | 4 | MM550 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 6.81e-05 | 225 | 26 | 4 | MM17079 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 1.01e-04 | 790 | 26 | 6 | M12490 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 1.06e-04 | 490 | 26 | 5 | MM1001 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 1.79e-04 | 289 | 26 | 4 | MM1238 | |
| Coexpression | JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN | 2.11e-04 | 302 | 26 | 4 | M38975 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK | 4.09e-04 | 147 | 26 | 3 | MM1316 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK | 4.17e-04 | 148 | 26 | 3 | M2420 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 4.68e-04 | 154 | 26 | 3 | M6695 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP | 5.05e-04 | 380 | 26 | 4 | M38974 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 5.33e-04 | 161 | 26 | 3 | M11857 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 6.07e-04 | 399 | 26 | 4 | M41172 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 6.40e-04 | 723 | 26 | 5 | MM3672 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN | 6.68e-04 | 174 | 26 | 3 | M381 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | 7.75e-04 | 426 | 26 | 4 | M41019 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 8.16e-04 | 432 | 26 | 4 | M41149 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 9.04e-04 | 444 | 26 | 4 | MM1051 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN | 9.57e-04 | 197 | 26 | 3 | M10015 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 9.71e-04 | 198 | 26 | 3 | M7948 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 9.85e-04 | 199 | 26 | 3 | M9501 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M9258 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN | 1.00e-03 | 200 | 26 | 3 | M7904 | |
| Coexpression | ENGELMANN_CANCER_PROGENITORS_UP | 1.04e-03 | 48 | 26 | 2 | M13135 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.04e-03 | 805 | 26 | 5 | MM1067 | |
| CoexpressionAtlas | PP_MEP_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.84e-05 | 424 | 21 | 5 | PP_MEP_2500_K4 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9 | 7.99e-05 | 139 | 27 | 3 | 6b58d01ce9d9ac23434333f9faf1bb0eef14ba90 | |
| ToppCell | C_02|World / shred on cell type and cluster | 1.33e-04 | 165 | 27 | 3 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.95e-04 | 188 | 27 | 3 | 2e268d8091e25d50bf05f26517d3ceb583801fd4 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.95e-04 | 188 | 27 | 3 | 59d5c7b147af118442adadf708ce2d1422b1e9aa | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.17e-04 | 195 | 27 | 3 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.17e-04 | 195 | 27 | 3 | c0ea25ed1a849e6efff885e98013a4f1d5134758 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 196 | 27 | 3 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | wk_08-11-Endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 196 | 27 | 3 | 0e545874083fd8e954a49fc397d57a86b081008b | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 2.24e-04 | 197 | 27 | 3 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 197 | 27 | 3 | 2ed92f942475db6836e48da3c6b8235eb8691c38 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 197 | 27 | 3 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | e3e2233c796d5e9051c8c1b66f70f406f048ed56 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 198 | 27 | 3 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | 8fac96132663f54566136ef54b53684d31dfde32 | |
| ToppCell | C_01|World / shred on cell type and cluster | 2.27e-04 | 198 | 27 | 3 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 198 | 27 | 3 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | wk_15-18-Endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 198 | 27 | 3 | dcf453e22dba90c0ae349fa6c3d4c20758bb95af | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 199 | 27 | 3 | 043c65bdf54a1bf0e483fea9ffc042ff5b271764 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 199 | 27 | 3 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | wk_20-22-Endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.31e-04 | 199 | 27 | 3 | 07be9509a8ec9c9a7d721912d77c20e841f49808 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 199 | 27 | 3 | ee981046217e8759610eb58a670d98f32cd83abc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 199 | 27 | 3 | ab71b312635a2b2c98d71b60a299f44bc80a3587 | |
| Drug | MeA alpha C | 2.17e-11 | 22 | 24 | 5 | CID000062244 | |
| Drug | acetaminophen glucuronide | 3.03e-11 | 59 | 24 | 6 | CID000083944 | |
| Drug | luciferyl sulfate | 3.32e-11 | 7 | 24 | 4 | CID011953812 | |
| Drug | dopamine-4-O-sulfate | 3.32e-11 | 7 | 24 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 3.32e-11 | 7 | 24 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 3.32e-11 | 7 | 24 | 4 | CID003035977 | |
| Drug | AalphaC | 3.50e-11 | 24 | 24 | 5 | CID000062805 | |
| Drug | 2-iodophenol | 6.63e-11 | 8 | 24 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 6.63e-11 | 8 | 24 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 6.63e-11 | 8 | 24 | 4 | CID003037707 | |
| Drug | Glu-P-2 | 9.74e-11 | 29 | 24 | 5 | CID000049970 | |
| Drug | acetaminophen sulfate | 1.39e-10 | 31 | 24 | 5 | CID000083939 | |
| Drug | EM-139 | 6.74e-10 | 13 | 24 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 9.44e-10 | 14 | 24 | 4 | CID000020908 | |
| Drug | deoxoestrone | 9.44e-10 | 14 | 24 | 4 | CID000005888 | |
| Drug | arylsulfate | 1.29e-09 | 15 | 24 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 1.29e-09 | 15 | 24 | 4 | CID000002895 | |
| Drug | salicylamide | 1.39e-09 | 48 | 24 | 5 | CID000005147 | |
| Drug | A-44 | 1.71e-09 | 16 | 24 | 4 | CID000120353 | |
| Drug | benzilic acid | 2.24e-09 | 17 | 24 | 4 | CID000006463 | |
| Drug | MeIQx | 2.80e-09 | 55 | 24 | 5 | CID000062275 | |
| Drug | AC1Q6OHG | 3.64e-09 | 19 | 24 | 4 | CID000115063 | |
| Drug | pedunculagin | 3.64e-09 | 19 | 24 | 4 | CID000442688 | |
| Drug | NSC36919 | 3.68e-09 | 58 | 24 | 5 | CID000235496 | |
| Drug | 4-hydroxyestrone | 4.02e-09 | 59 | 24 | 5 | CID000018418 | |
| Drug | PLP-Glu | 4.55e-09 | 20 | 24 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 5.61e-09 | 21 | 24 | 4 | CID000005895 | |
| Drug | 3-OHBaP | 5.63e-09 | 63 | 24 | 5 | CID000025890 | |
| Drug | epicatechin-3-gallate | 6.61e-09 | 65 | 24 | 5 | CID000065056 | |
| Drug | AABSSN | 6.86e-09 | 22 | 24 | 4 | CID005464134 | |
| Drug | taselin | 8.29e-09 | 23 | 24 | 4 | CID000023846 | |
| Drug | minoxidil sulphate | 1.18e-08 | 25 | 24 | 4 | CID000004202 | |
| Drug | 2-pentanone | 1.18e-08 | 25 | 24 | 4 | CID000007895 | |
| Drug | AzMC | 1.18e-08 | 25 | 24 | 4 | CID000064986 | |
| Drug | 7-hydroxycoumarin | 1.37e-08 | 75 | 24 | 5 | CID005281426 | |
| Drug | alpha-methyldopamine | 1.40e-08 | 26 | 24 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 1.40e-08 | 26 | 24 | 4 | CID000115245 | |
| Drug | 1m2q | 1.40e-08 | 26 | 24 | 4 | CID005326637 | |
| Drug | benzyloxyresorufin | 1.67e-08 | 78 | 24 | 5 | CID000114982 | |
| Drug | 3,3'-T2 | 2.55e-08 | 30 | 24 | 4 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 2.93e-08 | 31 | 24 | 4 | CID000122642 | |
| Drug | barium hydroxide | 2.93e-08 | 31 | 24 | 4 | CID000028387 | |
| Drug | Phosphoadenosine Phosphosulfate | 3.59e-08 | 7 | 24 | 3 | ctd:D010724 | |
| Drug | DCNP | 3.81e-08 | 33 | 24 | 4 | CID000012066 | |
| Drug | 4-aminobiphenyl | 3.86e-08 | 92 | 24 | 5 | CID000007102 | |
| Drug | p-nitroanisole | 3.86e-08 | 92 | 24 | 5 | CID000007485 | |
| Drug | 2-naphthol | 4.08e-08 | 93 | 24 | 5 | CID000008663 | |
| Drug | 1-naphthol | 5.31e-08 | 98 | 24 | 5 | CID000007005 | |
| Drug | N-hydroxy-4-aminobiphenyl | 5.74e-08 | 8 | 24 | 3 | ctd:C014593 | |
| Drug | mefenamic acid | 6.13e-08 | 37 | 24 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 6.84e-08 | 38 | 24 | 4 | CID000007518 | |
| Drug | d-equilenin | 9.37e-08 | 41 | 24 | 4 | CID000010597 | |
| Drug | 2-naphthylamine | 9.49e-08 | 110 | 24 | 5 | CID000007057 | |
| Drug | L-alpha-methyldopa | 1.03e-07 | 42 | 24 | 4 | CID000004138 | |
| Drug | Woodward's reagent K | 1.14e-07 | 43 | 24 | 4 | CID000077804 | |
| Drug | gallic acid | 1.24e-07 | 116 | 24 | 5 | CID000000370 | |
| Drug | NSC674039 | 1.25e-07 | 44 | 24 | 4 | CID000001249 | |
| Drug | 1IIg | 1.37e-07 | 45 | 24 | 4 | CID000001682 | |
| Drug | NDPS | 1.37e-07 | 45 | 24 | 4 | CID000090363 | |
| Drug | pentachlorophenol | 1.47e-07 | 120 | 24 | 5 | CID000000992 | |
| Drug | 4-octylphenol | 1.64e-07 | 47 | 24 | 4 | CID000015730 | |
| Drug | PhIP-HCl | 1.66e-07 | 123 | 24 | 5 | CID000001530 | |
| Drug | sulfamethazine | 1.79e-07 | 48 | 24 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 1.79e-07 | 48 | 24 | 4 | CID000005896 | |
| Drug | 2-acetylaminofluorene | 2.48e-07 | 262 | 24 | 6 | CID000005897 | |
| Drug | 9-hydroxybenzo(a)pyrene | 2.69e-07 | 53 | 24 | 4 | CID000028598 | |
| Drug | minoxidil | 2.90e-07 | 54 | 24 | 4 | CID000004201 | |
| Drug | androstenediol | 2.90e-07 | 54 | 24 | 4 | CID000010634 | |
| Drug | aniline | 3.40e-07 | 142 | 24 | 5 | CID000006115 | |
| Drug | 4-nonylphenol | 5.78e-07 | 64 | 24 | 4 | CID000001752 | |
| Drug | estrone sulfate | 6.73e-07 | 163 | 24 | 5 | CID000000699 | |
| Drug | estrone-d4 | 7.82e-07 | 168 | 24 | 5 | CID000000698 | |
| Drug | Pyrethroids | 8.80e-07 | 71 | 24 | 4 | CID000005053 | |
| Drug | adenylylsulfate | 9.31e-07 | 72 | 24 | 4 | CID000000228 | |
| Drug | 4-nitrophenol | 1.01e-06 | 177 | 24 | 5 | CID000000980 | |
| Drug | 5-hydroxymethylfurfural | 1.06e-06 | 2 | 24 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 1.06e-06 | 2 | 24 | 2 | ctd:C012365 | |
| Drug | Hydroxytryptophol | 1.06e-06 | 2 | 24 | 2 | ctd:D006917 | |
| Drug | 4-hydroxyestradiol | 1.35e-06 | 79 | 24 | 4 | CID000001743 | |
| Drug | reverse T3 | 1.57e-06 | 82 | 24 | 4 | CID000022069 | |
| Drug | N-NH | 2.05e-06 | 24 | 24 | 3 | CID000446124 | |
| Drug | DB07328 | 2.24e-06 | 208 | 24 | 5 | CID011840913 | |
| Drug | DiMeIQx | 2.96e-06 | 27 | 24 | 3 | CID000104739 | |
| Drug | 5-hydroxyindole | 3.19e-06 | 3 | 24 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 3.19e-06 | 3 | 24 | 2 | ctd:D008914 | |
| Drug | 5-hydroxy-3-methylindole | 3.19e-06 | 3 | 24 | 2 | CID000192734 | |
| Drug | 8-azaadenine | 3.19e-06 | 3 | 24 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 3.19e-06 | 3 | 24 | 2 | ctd:C030629 | |
| Drug | adenosine 3'-5'-diphosphate | 3.21e-06 | 98 | 24 | 4 | CID000000073 | |
| Drug | 1 C2 | 3.48e-06 | 100 | 24 | 4 | CID005327152 | |
| Drug | A21250 | 4.23e-06 | 105 | 24 | 4 | CID000000990 | |
| Drug | phenolate | 5.94e-06 | 254 | 24 | 5 | CID000000996 | |
| Drug | dopamine | 6.35e-06 | 715 | 24 | 7 | CID000000681 | |
| Drug | Chebi:32701 | 6.38e-06 | 4 | 24 | 2 | CID005460855 | |
| Drug | phenylglyoxal | 7.43e-06 | 121 | 24 | 4 | CID000014090 | |
| Drug | acetaminophen | 7.99e-06 | 270 | 24 | 5 | CID000001983 | |
| Drug | tyramine | 9.87e-06 | 130 | 24 | 4 | CID000005610 | |
| Drug | pinocembrin | 1.06e-05 | 5 | 24 | 2 | ctd:C016063 | |
| Drug | TKPP | 1.06e-05 | 5 | 24 | 2 | CID000023740 | |
| Drug | harmol | 1.06e-05 | 5 | 24 | 2 | ctd:C001326 | |
| Disease | X-12707 measurement | 4.16e-05 | 12 | 24 | 2 | EFO_0800720 | |
| Disease | ascorbic acid 3-sulfate measurement | 5.74e-05 | 14 | 24 | 2 | EFO_0800173 | |
| Disease | Chromosome Aberrations | 7.56e-05 | 16 | 24 | 2 | C0008625 | |
| Disease | Autosome Abnormalities | 7.56e-05 | 16 | 24 | 2 | C0004403 | |
| Disease | basophil count | 6.83e-03 | 483 | 24 | 3 | EFO_0005090 | |
| Disease | alkaline phosphatase measurement | 8.54e-03 | 1015 | 24 | 4 | EFO_0004533 | |
| Disease | chronic kidney disease | 1.55e-02 | 235 | 24 | 2 | EFO_0003884 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVWYQEVWNDEFLSW | 81 | O95264 | |
| WHIYQDWHSFLLWEF | 166 | Q16854 | |
| YRDWWNSESVTYFWQ | 361 | O75907 | |
| LTWLYFWWEVHNDYD | 56 | Q8WTR4 | |
| FWWEVHNDYDEFNWY | 61 | Q8WTR4 | |
| VLCQGWHYLAYDWHW | 361 | O95163 | |
| WHYLAYDWHWTTDRS | 366 | O95163 | |
| EECYWGHVFWDQDLW | 291 | Q32M88 | |
| VAYVLQDWWLSYWAN | 726 | O15439 | |
| EFAWDWLEVHYWTSR | 346 | Q9NZS9 | |
| EAAAWYWHFVDVVWL | 236 | P00414 | |
| KSYFREWLYNALWWH | 381 | Q92839 | |
| DYWYETSFWLLWANS | 391 | Q9Y5N1 | |
| NLEWLSSLWDWYTSY | 451 | O00237 | |
| RFQVTHFSWYWLWYT | 581 | Q9HB75 | |
| HFERWSHRYDEWIYW | 46 | A8MW92 | |
| YYWEVHVGDSWNWAF | 341 | P0CI25 | |
| WQVSLRVYSYHWASW | 81 | A6NIE9 | |
| EVSYGSWYQHVQEWW | 166 | P0DMN0 | |
| EVSYGSWYQHVQEWW | 166 | P0DMM9 | |
| EVSYGSWYQHVQEWW | 166 | P50225 | |
| EVSYGSWYQHVQEWW | 166 | P50226 | |
| YYWEVHMGDSWNWAF | 341 | Q9BSJ1 | |
| YYWEVHVGDSWNWAF | 341 | P0CI26 | |
| YVTWFFWFWNDLNFL | 371 | Q8IUH5 | |
| YYWEVHVGDSWNWAF | 341 | C9J1S8 | |
| YYWEVHVGDSWNWAF | 341 | A6NDI0 | |
| CNYYYELWWFWLVWT | 36 | Q9NX94 | |
| TYYYELWWFWLLWTV | 51 | Q96G27 | |
| WFYTRWKDWESWYSQ | 476 | Q9UGI0 |